Specific Diagnostics logo
Startup

Specific Diagnostics

See Specific Diagnostics's full profile

BOOK A DEMO
Headquarters

United States

Founded Year

2019

Total Funding

$12.5M

Employees

11 - 50

Status

Active


About Specific Diagnostics

Therefore, it is critical the right antibiotic treatment is determined quickly. Current methodologies require 3 days to determine the effective antibiotic.

Headquarters

Mountain View, United States


General Information on Specific Diagnostics

Brand name Specific Diagnostics
Company name Specific Diagnostics Inc.
Website https://specificdx.com/
Founded year 2019
Employees 11 - 50
Founding team

Ray Martino

Contact [email protected]

Find startup solutions in your specific business context

The INNOSPOT Startup Discovery platform helps you to find the right startup solutions by leveraging the world's most powerful Startup Search Engine analyzing millions of data points.
BOOK A DEMO

Recent News and Activity about Specific Diagnostics

Cercle Finance 19.05.2022
bioMérieux: completes acquisition of Specific Diagnostics

rapid antibiotic susceptibility testing system that provides a phenotypic antibiotic susceptibility test (AST) directly from positive blood cultures. The French group acquired the company for a price equivalent to 3.2% of its own market capitalisation, in a combination of cash and 1,288,901 new shares issued to certain Specific Diagnostics shareholders. bioMérieux will shortly launch a share buyback program to offset this dilution. With this ...

PressReleasePoint 21.04.2022
bioMerieux strengthens its commitment to fight antimicrobial resistance with the acquisition of Specific Diagnostics, an innovative company focusing on fast AST solution

diagnostics, announces that it has entered into an agreement to acquire Specific Diagnostics, a privately held U.S. based company that has developed a rapid antimicrobial susceptibility test (AST) system that delivers phenotypic AST directly from positive blood cultures. bioMérieux has held a minority stake in Specific Diagnostics since 2019, and the two companies had signed a co-distribution agreement covering the European market in 2021. ...

Lab Medica 13.04.2022
BioMérieux Acquires Antibiotic Susceptibility Test Firm Specific Diagnostics

bioMérieux (Marcy-l'Étoile, France) has further strengthened its commitment to fight AMR with the acquisition of Specific Diagnostics (San Jose, CA, USA) which focuses on fast AST solution. Specific has developed a rapid AST system that delivers phenotypic AST directly from positive blood cultures. The SPECIFIC REVEAL Rapid AST system has been developed based on the company’s unique, patented metabolomic signature technology and offers an ...

Specific Diagnostics news
NS Medical Devices 13.04.2022
bioMérieux strengthens its commitment to fight antimicrobial resistance with the acquisition of Specific Diagnostics, an innovative company focusing on fast AST solution

In addition to improving patient outcomes, rapid AST also reduces global AMR burdens by enabling the implementation of effective institutional Antimicrobial Stewardship (AMS) programs. In perfect alignment with bioMérieux’s priority to provide innovative diagnostics to support Antimicrobial Stewardship, the SPECIFIC REVEAL Rapid AST system provides actionable results for Gram-negative bacteria directly from positive blood cultures in an average ...

Specific Diagnostics news
WFMZ Allentown 15.02.2022
Specific Diagnostics Invited to Present at the BTIG Virtual MedTech, Digital Health, Life Science Tools and Diagnostics Investor Conference

Feb. 14, 2022 /PRNewswire-PRWeb/ -- Specific Diagnostics has been invited to present at the BTIG Virtual MedTech, Digital Health, Life Science Tools and Diagnostics Conference on February 15th , and annual event hosted exclusively for prospective and existing BTIG clients. "Specific has begun its commercial deployment," said Dr. Paul A. Rhodes , Specific's CEO, "with clinical trials commencing in the US, CE mark registration, and our launch of ...

Specific Diagnostics news
sogotradedev.websol.barchart.com 14.02.2022
Specific Diagnostics Invited to Present at the BTIG Virtual MedTech, Digita

Science Tools and Diagnostics Conference on February 15th , and annual event hosted exclusively for prospective and existing BTIG clients. Clinicians often wait 2 days following availability of a positive blood culture sample to receive the antibiotic susceptibility testing (AST) results required to guide effective antibiotic therapy, which ID results alone do not enable. This delay results in overuse of costly broad-spectrum antibiotic ...

Jotup 08.10.2021
Specific Diagnostics Commences US Clinical Trials for FDA 510(k) Clearance of its Reveal Rapid AST System

Information Retrieved on: Thursday, October 7, 2021 - 6:50pm Organisation: Specific Diagnostics Website: Geotags: Content Key Points: MOUNTAIN VIEW, Calif., Oct. 7, 2021 /PRNewswire-PRWeb/ -- Specific Diagnostics announces today the commencement of its US clinical studies for the Reveal Rapid AST System for blood infection. Trials will entail 3 months of data collection followed by submission for FDA consideration of 510(k) clearance of the ...

sogotradedev.websol.barchart.com 07.10.2021
Specific Diagnostics Commences US Clinical Trials for FDA 510(k) Clearance

Trials will entail 3 months of data collection followed by submission for FDA consideration of 510(k) clearance of the Reveal test.Reveal determines the susceptibility of blood infections to antimicrobial drugs in an average of 5 hours, allowing same-shift adjustment of treatment, saving lives while reducing costs and improving the utilization of antibiotics.Reveal's CE-marked, low cost, high throughput, broad menu, and small footprint are all ...

Jotup 06.10.2021
Scott Mendel, former GenMark CEO, Joins Specific Diagnostics' Board of Advisors

Content Key Points: MOUNTAIN VIEW, Calif., Oct. 5, 2021 /PRNewswire-PRWeb/ --Specific Diagnostics today announced the appointment of Scott Mendel to its Board of Advisors. Prior to joining GenMark, Mr. Mendel held CFO positions at The Active Network and GE Healthcare. "I am glad to welcome my former GenMark colleague and CEO to Specific at this critical time in our commercial launch," noted Johnny Ek, Specific CFO and former GenMark CFO. "I'm ...

BizWire Express 05.10.2021
Scott Mendel, former GenMark CEO, Joins Specific Diagnostics’ Board of Advisors

Specific Diagnostics today announced the appointment of Scott Mendel to its Board of Advisors. Mr. Mendel is an industry veteran with over 30 years in public and private corporate leadership. Mr. Mendel had served since 2020 as the Chief Executive Officer of public company GenMark, overseeing its rapid growth to $200M in annual sales, and the process that led to its purchase by Roche Diagnostics for $1.8B in Q2 of this year.MOUNTAIN VIEW, Calif. ...